Tower Research Capital LLC (Trc) F Star Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$4.09 - $6.86 $116,867 - $196,017	-28,574 Reduced 88.47%	3,724 $24,000
Q3 2022 Nov 10, 2022	BUY	$5.41 - $6.74 $174,732 - $217,688	32,298 New	32,298 $165,000
Q2 2022 Aug 15, 2022	SELL	$2.18 - $6.39 $6,681 - $19,585	-3,065 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$2.77 - $5.36 $21,273 - $41,164	-7,680 Reduced 71.48%	3,065 $11,000
Q4 2021 Feb 14, 2022	BUY	$4.71 - $7.38 $49,803 - $78,036	10,574 Added 6183.63%	10,745 $54,000
Q3 2021 Nov 15, 2021	BUY	$5.2 - $8.42 $889 - $1,439	171 New	171 $1,000

44.7K

Ticker FSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,584,700
Description
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.